CYBB and neurodegenerative disease: Under pathophysiological conditions, intensified NOX2 activity promotes ET-1 production in ECs, which mediates pro-inflammatory microglia activation and neuroinflammation, involved in vascular disruption and disruption of the blood-brain barrier in neurodegenerative diseases [49–51].